PAI-1 gain-of-function genotype, factors increasing PAI-1 levels, and airway obstruction: the GALA II Cohort

Abstract

Background

PAI-1 gain of function variants promote airway fibrosis, and are associated with asthma and with worse lung function in subjects with asthma.

Objective

We sought to determine if the association of a gain-of-function polymorphism in Plasminogen Activator Inhibitor -1 (PAI-1) with airway obstruction is modified by asthma status, and whether any genotype effect persists after accounting for common exposures that increase PAI-1 level.

Methods

We studied 2070 Latino children (8-21y) with genotypic and pulmonary function data from the GALA II cohort. We estimated the relationship of the PAI-1 risk allele with FEV1/FVC by multivariate linear regression, stratified by asthma status. We examined the association of the polymorphism with asthma and airway obstruction within asthmatics via multivariate logistic regression. We replicated associations in the SAPPHIRE cohort of African Americans (n=1056). Secondary analysis included the effect of the at-risk polymorphism on post bronchodilator lung function.

Results

There was an interaction between asthma status and the PAI-1 polymorphism on FEV₁/FVC (p=0.03). The gain-of-function variants, genotypes (AA/AG), were associated with lower FEV₁/FVC in subjects with asthma (β=-1.25, CI:-2.14,-0.35, p=0.006), but not in controls. Subjects with asthma and the AA/AG genotypes had a 5% decrease in FEV₁/FVC (p<0.001). In asthmatics, the risk genotype (AA/AG) was associated with a 39% increase in risk of clinically relevant airway obstruction (OR=1.39, CI:1.01, 1.92, p=0.04). These associations persisted after exclusion of factors that increase PAI-1 including tobacco exposure and obesity.

Conclusions and Clinical Relevance

The decrease in the FEV₁/FVC ratio associated with the risk genotype was modified by asthma status. The genotype increased the odds of airway obstruction by 75% within asthmatics only. Since exposures known to increase PAI-1 levels did not mitigate this association, PAI-1 may contribute to airway obstruction in the context of chronic asthmatic airway inflammation.

This article is protected by copyright. All rights reserved.

http://ift.tt/2rzitJM